PMC:7665480 / 20998-21127 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"451","span":{"begin":52,"end":62},"obj":"Chemical"},{"id":"454","span":{"begin":78,"end":86},"obj":"Disease"}],"attributes":[{"id":"A451","pred":"tao:has_database_id","subj":"451","obj":"MESH:D000068338"},{"id":"A454","pred":"tao:has_database_id","subj":"454","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Some authors claim a possible beneficial effect for everolimus as therapy for COVID-19 due to its immunomodulatory activity [27]."}

    TEST0

    {"project":"TEST0","denotations":[{"id":"33084868-125-131-8440","span":{"begin":125,"end":127},"obj":"[\"32574238\"]"}],"text":"Some authors claim a possible beneficial effect for everolimus as therapy for COVID-19 due to its immunomodulatory activity [27]."}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T222","span":{"begin":0,"end":129},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Some authors claim a possible beneficial effect for everolimus as therapy for COVID-19 due to its immunomodulatory activity [27]."}